Improved Measurement of Drug Exposure in the Brain Using Drug-Specific Correction for Residual Blood
Open Access
- 16 September 2009
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 30 (1), 150-161
- https://doi.org/10.1038/jcbfm.2009.200
Abstract
A major challenge associated with the determination of the unbound brain-to-plasma concentration ratio of a drug ( Kp,uu,brain), is the error associated with correction for the drug in various vascular spaces of the brain, i.e., in residual blood. The apparent brain vascular spaces of plasma water ( Vwater, 10.3 μL/g brain), plasma proteins ( Vprotein, 7.99 μL/g brain), and the volume of erythrocytes ( Ver, 2.13 μL/g brain) were determined and incorporated into a novel, drug-specific correction model that took the drug-unbound fraction in the plasma ( fu,p) into account. The correction model was successfully applied for the determination of Kp,uu,brain for indomethacin, loperamide, and moxalactam, which had potential problems associated with correction. The influence on correction of the drug associated with erythrocytes was shown to be minimal. Therefore, it is proposed that correction for residual blood can be performed using an effective plasma space in the brain ( Veff), which is calculated from the measured fu,p of the particular drug as well as from the estimates of Vwater and Vprotein, which are provided in this study. Furthermore, the results highlight the value of determining Kp,uu,brain with statistical precision to enable appropriate interpretation of brain exposure for drugs that appear to be restricted to the brain vascular spaces.Keywords
This publication has 28 references indexed in Scilit:
- Development of a High-Throughput Brain Slice Method for Studying Drug Distribution in the Central Nervous SystemDrug Metabolism and Disposition, 2009
- Peripheral and central H1 histamine receptor occupancy by levocetirizine, a non‐sedating antihistamine; a time course study in the guinea pigBritish Journal of Pharmacology, 2007
- In Vitro Methods for Estimating Unbound Drug Concentrations in the Brain Interstitial and Intracellular FluidsDrug Metabolism and Disposition, 2007
- Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamicsAdvanced Drug Delivery Reviews, 2004
- Efflux transport systems for drugs at the blood–brain barrier and blood–cerebrospinal fluid barrier (Part 1)Drug Discovery Today, 2001
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.JCI Insight, 1996
- Microwave Fixation for the Determination of Cerebral Blood Volume in RatsJournal of Cerebral Blood Flow & Metabolism, 1993
- Continuous measurement of cerebral blood volume in rats with the photoelectric technique: Effect of morphine and naloxoneLife Sciences, 1986
- Defining the lower limits of blood‐brain barrier permeability: Factors affecting the magnitude and interpretation of permeability‐area productsJournal of Neuroscience Research, 1986
- Regional Brain Blood Flow, Blood Volume, and Haematocrit Values in the Adult RatJournal of Cerebral Blood Flow & Metabolism, 1983